Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | GSK3B | P49841 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11737575 | 0.84 | ALDH1A1 (0.61) | ALDH1A1GSK3BMAPK1HIF1ATRPA1 | |
| SCHEMBL3920221 | 0.83 | GSK3B (0.44) | ALDH1A1GSK3BHPGDMAPK1HIF1A | |
| SCHEMBL28053559 | 0.82 | ALDH1A1 (0.53) | ALDH1A1HPGDMAPK1SMN1; SMN2HSD17B10 | |
| SCHEMBL15979732 | 0.82 | ALDH1A1 (0.53) | ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL30089542 | 0.82 | ALDH1A1 (0.53) | ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL166468 | 0.80 | PTPN1 (0.57) | ALDH1A1GSK3BHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL29758522 | 0.80 | PTPN1 (0.57) | ALDH1A1GSK3BHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL3703924 | 0.80 | ALDH1A1 (0.51) | ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL8740774 | 0.80 | PTPN1 (0.57) | ALDH1A1GSK3BHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL5660953 | 0.79 | ALDH1A1 (0.47) | ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107674068-A | A kind of method for synthesizing Rynaxypyr derivatives intermediates | 浙江工业大学 | 2018-02-09 | — | — | CN | claimed |
| US-20230232703-A1 | LIGHT EMITTING ELEMENT AND ORGANOMETALLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230232703-A1 | LIGHT EMITTING ELEMENT AND ORGANOMETALLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-20 | — | — | US | disclosed |
| CN-107674068-A | A kind of method for synthesizing Rynaxypyr derivatives intermediates | 浙江工业大学 | 2018-02-09 | — | — | CN | disclosed |
| EP-3260445-A1 | COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR | Universität Konstanz (DE) | 2017-12-27 | — | — | EP | disclosed |
| EP-1741693-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | NAGOYA IND SCIENCE RES INST (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-7741317-B2 | LXR modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-06-22 | — | — | US | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070093470-A1 | LXR modulators | BRISTOL-MYERS SQUIBB COMPANY | 2007-04-26 | — | — | US | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
| EP-0783505-B1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 2001-03-07 | — | — | EP | disclosed |
| US-5869485-A | Pyrrolo 2,3-d!pyrimidines and their use | NOVARTIS FINANCE CORP. (US) | 1999-02-09 | — | — | US | disclosed |
| EP-0783505-A1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | Novartis AG (CH) | 1997-07-16 | — | — | EP | disclosed |
| WO-1996010028-A1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 1996-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | ALDH1A1 277/4885GSK3B 2227/4885HPGD 270/4885 |
| US-20070093470-A1 | LXR modulators | NR1H2, NR1H3, RXRB | ALDH1A1 2274/4885GSK3B 447/4885HPGD 2520/4885 |
| US-20230232703-A1 | LIGHT EMITTING ELEMENT AND ORGANOMETALLIC COMPOUND FOR THE SAME | NFE2L2, CRY1, GPX1 | ALDH1A1 154/4885GSK3B 4486/4885HPGD 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.